特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
498210

血管ステントの世界市場 - 2021年までの予測:ベアメタルステント、生体吸収性ステント、薬剤溶出ステント

Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 191 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
血管ステントの世界市場 - 2021年までの予測:ベアメタルステント、生体吸収性ステント、薬剤溶出ステント
出版日: 2017年05月03日
発行: MarketsandMarkets
ページ情報: 英文 191 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の血管ステント市場は、2016年の122億1000万米ドルから、2021年までに176億8000万米ドルまで拡大すると見られています。市場は、2016年~2021年のCAGR (複合年間成長率) で、7.7%の成長が予測されています。

当レポートでは、世界の血管ステント市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

FIGURE 13 VASCULAR STENTS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 血管ステント:市場概要
  • 血管ステント市場:製品別
  • 血管ステント市場:デリバリーモード別
  • 血管ステント市場:材料別
  • 末梢血管ステント市場:種類別
  • 血管ステント市場:エンドユーザー別
  • 地域別スナップショット:血管ステント市場

第5章 血管ステントの世界市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 規制情勢
  • 製品パイプライン

第6章 血管ステントの世界市場:種類別

  • イントロダクション
  • 薬剤溶出ステント
  • ベアメタルステント
  • 生体吸収性ステント

第7章 血管ステントの世界市場:製品別

  • イントロダクション
  • 冠動脈ステント
  • 末梢ステント
  • 血管内動脈瘤修復(EVAR) ステントグラフト

第8章 血管ステントの世界市場:デリバリーモード別

  • イントロダクション
  • バルーン拡張型ステント
  • 自己拡張型ステント

第9章 血管ステントの世界市場:材料別

  • イントロダクション
  • 金属ステント
  • その他

第10章 血管ステントの世界市場:エンドユーザー別

  • イントロダクション
  • 病院、心臓病センター
  • 外来外科センター

第11章 血管ステントの世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合情勢

  • 概要
  • 市場ランキング分析
  • ベンダー概要
  • 事業戦略
  • 製品

第13章 企業プロファイル

  • イントロダクション
  • MEDTRONIC PLC
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • BIOTRONIK SE & CO. KG
  • B. BRAUN MELSUNGEN AG
  • テルモ
  • MICROPORT SCIENTIFIC CORPORATION
  • MERIL LIFE SCIENCES PVT. LTD.
  • VASCULAR CONCEPTS LIMITED
  • C.R. BARD, INC.
  • W.L. GORE AND ASSOCIATES, INC.
  • ENDOLOGIX, INC.
  • LOMBARD MEDICAL
  • TRANSLUMINA GMBH
  • JOTEC GMBH

第14章 付録

目次
Product Code: MD 5228

The global vascular stents market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% from 2016 to 2021.

Major factors contributing to the growth of the global vascular stents market include technological advancements, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population. However, the presence of alternative treatments for cardiovascular diseases, stringent regulations for product approvals, and numerous cases of product failure and recalls are the major factors that are expected to restrain the growth of this market during the forecast period of 2016 to 2021.

Various companies are focusing on R&D activities to improve their vascular stent offerings. Companies like Abbott Laboratories and Boston Scientific are focusing on the development of biodegradable stents to offer effective products that overcome the complications caused by thrombosis [resulting from long-term device implantation]. For instance, in May 2014, Boston Scientific (U.S.) launched the Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Japan.

Currently, the vascular stents market is witnessing a new phase of technology development with the launch of fully dissolving stents. In July 2016, Abbott Laboratories (U.S.) received the U.S. FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the fully dissolving stent approved for the treatment of CAD. Furthermore, a number of bioabsorbable stents for treating PAD are in clinical trials. Some of these products include 480 Biomedical's Stanza bioresorbable self-expanding scaffold [which is currently under SPIRIT trial and will be used to treat PAD for superficial femoral artery (SFA)] and the Esprit bioresorbable vascular scaffold (BVS) from Abbott Vascular [will be used in the treatment of PAD for SFA and iliac lesions].

The Asian market is estimated to register the highest growth during the forecast period. The high-growth in this regional segment can be attributed to the presence of a large population base, growing prevalence of vascular diseases, rising adoption of advanced technologies, and low manufacturing costs for medical devices in emerging Asian countries.

Research Coverage:

This market is categorized on the basis of product, type, mode of delivery, material, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the vascular stents market. The report analyzes this market by product, type, mode of delivery, material, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the vascular stents market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the vascular stents market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for vascular stents across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular stents market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. VASCULAR STENTS: MARKET OVERVIEW
  • 4.2. VASCULAR STENTS MARKET, BY PRODUCT (2016-2021)
  • 4.3. VASCULAR STENTS MARKET, BY MODE OF DELIVERY (2016 VS. 2021)
  • 4.4. VASCULAR STENTS MARKET, BY MATERIAL (2016 VS. 2021)
  • 4.5. PERIPHERAL VASCULAR STENTS MARKET, BY TYPE (2016)
  • 4.6. VASCULAR STENTS MARKET, BY END USER (2016 VS. 2021)
  • 4.7. GEOGRAPHIC SNAPSHOT: VASCULAR STENTS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Innovations in Stenting Technologies
      • 5.2.1.2. Rising Incidence of Vascular Diseases and Subsequent Growth in the Number of Angioplasty Procedures
      • 5.2.1.3. Increasing Preference for Minimally Invasive Procedures
      • 5.2.1.4. Rapid Growth in the Geriatric Population
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Availability of Alternative Treatment Methods for Vascular Diseases
      • 5.2.2.2. Product Failures and Recalls
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Development of Bioresorbable Stents
      • 5.2.3.2. Emerging Markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Complications Associated with Stent Implantation
      • 5.2.4.2. Declining Costs of Stents
  • 5.3. REGULATORY LANDSCAPE
  • 5.4. PRODUCT PIPELINE

6. VASCULAR STENTS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. DRUG-ELUTING STENTS
  • 6.3. BARE-METAL STENTS
  • 6.4. BIOABSORBABLE STENTS

7. VASCULAR STENTS MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. CORONARY STENTS
  • 7.3. PERIPHERAL STENTS
    • 7.3.1. CAROTID ARTERY STENTS
    • 7.3.2. RENAL ARTERY STENTS
    • 7.3.3. FEMORAL ARTERY STENTS
    • 7.3.4. ILIAC ARTERY STENTS
    • 7.3.5. OTHER PERIPHERAL STENTS
  • 7.4. EVAR STENT GRAFTS
    • 7.4.1. ABDOMINAL AORTIC ANEURYSM STENTS
    • 7.4.2. THORACIC AORTIC ANEURYSM STENTS

8. VASCULAR STENTS MARKET, BY MODE OF DELIVERY

  • 8.1. INTRODUCTION
  • 8.2. BALLOON-EXPANDABLE STENTS
  • 8.3. SELF-EXPANDING STENTS

9. VASCULAR STENTS MARKET, BY MATERIAL

  • 9.1. INTRODUCTION
  • 9.2. METALLIC STENTS
    • 9.2.1. COBALT CHROMIUM
    • 9.2.2. PLATINUM CHROMIUM
    • 9.2.3. NICKEL TITANIUM
    • 9.2.4. STAINLESS STEEL
  • 9.3. OTHER STENTS

10. VASCULAR STENTS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITALS AND CARDIAC CENTERS
  • 10.3. AMBULATORY SURGICAL CENTERS

11. VASCULAR STENTS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. REST OF EUROPE
  • 11.4. ASIA
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET RANKING ANALYSIS, VASCULAR STENTS MARKET
  • 12.3. VENDOR DIVE OVERVIEW
    • 12.3.1. VANGUARDS
    • 12.3.2. DYNAMIC PLAYERS
    • 12.3.3. INNOVATORS
    • 12.3.4. EMERGING PLAYERS
  • 12.4. BUSINESS STRATEGY (FOR ALL 25 PLAYERS)
  • 12.5. PRODUCT OFFERINGS (FOR ALL 25 PLAYERS)

Top 25 companies analyzed for this study are - Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Biosensors International (Singapore), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Braile Biomedica (Brazil), C. R. Bard (U.S.), Cook Medical (U.S.), Cordis Corporation (U.S.), Endologix, Inc. (U.S.), GRINM Advanced Materials Co., Ltd (China), InSitu Technologies (U.S.), JOTECH GmBH (Germany), Lifetech Scientific Inc. (China), Lombard Medical (U.K.), Medtronic plc (Ireland), Meril Life Sciences (India), Microport Scientifc Corporation (China), OrbusNeich (Hong Kong), S&G Biotech (South Korea), STENTYS S.A. (France), Terumo Corporation (Japan), Translumina GmBH (Germany), Vascular Concepts (India), and W. L. Gore & Associates (U.S.).

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. MEDTRONIC PLC
  • 13.3. ABBOTT LABORATORIES
  • 13.4. BOSTON SCIENTIFIC CORPORATION
  • 13.5. BIOTRONIK SE & CO. KG
  • 13.6. B. BRAUN MELSUNGEN AG
  • 13.7. TERUMO CORPORATION
  • 13.8. MICROPORT SCIENTIFIC CORPORATION
  • 13.9. MERIL LIFE SCIENCES PVT. LTD.
  • 13.10. VASCULAR CONCEPTS LIMITED
  • 13.11. C.R. BARD, INC.
  • 13.12. W.L. GORE AND ASSOCIATES, INC.
  • 13.13. ENDOLOGIX, INC.
  • 13.14. LOMBARD MEDICAL
  • 13.15. TRANSLUMINA GMBH
  • 13.16. JOTEC GMBH

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PROJECTED INCREASE IN THE GLOBAL POPULATION BETWEEN 2005 AND 2030, BY AGE
  • TABLE 2: OTHER IMPORTANT MEDICAL DEVICE REGULATIONS
  • TABLE 3: VASCULAR STENTS MARKET: PIPELINE PRODUCTS
  • TABLE 4: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: COMMERCIALLY AVAILABLE DRUG-ELUTING STENTS
  • TABLE 6: DRUG-ELUTING STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: COMMERCIALLY AVAILABLE BARE-METAL STENTS
  • TABLE 10: BARE-METAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NORTH AMERICA: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: EUROPE: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NORTH AMERICA: BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: EUROPE: BIOABSORBABLE STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 17: CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 19: NORTH AMERICA: CORONARY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: CORONARY STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL PREVALENCE OF PAD, 2010
  • TABLE 22: PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS)
  • TABLE 24: NORTH AMERICA: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: EUROPE: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: PERIPHERAL STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: RENAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: FEMORAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: ILIAC ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: OTHER PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (NO. OF PROCEDURES)
  • TABLE 34: NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: AAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL TAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 40: COMMERCIALLY AVAILABLE BALLOON-EXPANDABLE VASCULAR STENTS
  • TABLE 41: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: EUROPE: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: COMMERCIALLY AVAILABLE SELF-EXPANDING STENTS
  • TABLE 45: SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 49: METALLIC VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: METALLIC VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 53: COMMERCIALLY AVAILABLE COBALT CHROMIUM VASCULAR STENTS
  • TABLE 54: COBALT CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: COMMERCIALLY AVAILABLE PLATINUM CHROMIUM VASCULAR STENTS
  • TABLE 56: PLATINUM CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: COMMERCIALLY AVAILABLE NICKEL TITANIUM VASCULAR STENTS
  • TABLE 58: NICKEL TITANIUM VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: COMMERCIALLY AVAILABLE STAINLESS STEEL VASCULAR STENTS
  • TABLE 60: STAINLESS STEEL VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: OTHER COMMERCIALLY AVAILABLE VASCULAR STENTS
  • TABLE 62: OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 63: NORTH AMERICA: OTHER VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 66: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: VASCULAR STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 75: NORTH AMERICA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 79: NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 80: NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 82: U.S.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 83: U.S.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: U.S.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 85: U.S.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 86: U.S.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: CANADA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 88: CANADA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: CANADA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 90: CANADA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 91: CANADA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 92: EUROPE: VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 93: EUROPE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 94: EUROPE: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: EUROPE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: EUROPE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 98: EUROPE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 99: EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: EUROPE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 101: GERMANY: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 102: GERMANY: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: GERMANY: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 104: GERMANY: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 105: GERMANY: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 106: FRANCE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 107: FRANCE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: FRANCE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 109: FRANCE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 110: FRANCE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 111: U.K.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 112: U.K.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: U.K.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 114: U.K.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 115: U.K.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 116: ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2007 VS. 2014 (% OF GDP)
  • TABLE 117: ROE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 118: ROE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: ROE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 120: ROE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 121: ROE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 122: ASIA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 123: ASIA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: ASIA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: ASIA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: ASIA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 127: ASIA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 128: ASIA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: ASIA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 130: ROW: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 131: ROW: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: ROW: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: ROW: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 134: ROW: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014-2021 (USD MILLION)
  • TABLE 135: ROW: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 136: ROW: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 137: ROW: VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 138: TOP 3 PLAYERS IN THE VASCULAR STENTS MARKET, 2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 7: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8: DRUG-ELUTING STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 9: BALLOON-EXPANDABLE STENTS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 10: CORONARY STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 11: HOSPITALS AND CARDIAC CENTERS FORM MAJOR END USERS OF VASCULAR STENTS
  • FIGURE 12: NORTH AMERICA DOMINATED THE VASCULAR STENTS MARKET IN 2016
  • FIGURE 13: RISING BURDEN OF VASCULAR DISEASES AND INNOVATIONS IN STENTING TECHNOLOGIES ARE DRIVING THE MARKET GROWTH FOR VASCULAR STENTS DURING THE FORECAST PERIOD
  • FIGURE 14: CORONARY STENTS DOMINATED THE VASCULAR STENTS MARKET IN 2016
  • FIGURE 15: BALLOON-EXPANDABLE STENTS FORM THE LARGEST MARKET SEGMENT
  • FIGURE 16: METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: CAROTID STENTS TO DOMINATE THE PERIPHERAL VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: HOSPITALS AND CARDIAC CENTERS FORMED THE LARGEST END USERS IN 2016
  • FIGURE 19: ASIA TO REGISTER THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 20: VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21: BIOABSORBABLE STENTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 22: ASIA TO GROW AT THE HIGHEST CAGR IN THE DRUG-ELUTING STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: EVAR STENT GRAFTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 24: ASIA TO GROW AT THE HIGHEST CAGR IN THE PERIPHERAL STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: BALLOON-EXPANDABLE STENTS TO DOMINATE MARKET FROM 2016 TO 2021
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE BALLOON-EXPANDABLE STENTS MARKET FROM 2016 TO 2021
  • FIGURE 27: METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 28: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE IN THE METALLIC STENTS MARKET
  • FIGURE 29: HOSPITALS AND CARDIAC CENTERS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA TO DOMINATE THE MARKET FOR HOSPITALS AND CARDIAC CENTERS (2016-2021)
  • FIGURE 31: NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL VASCULAR STENTS MARKET IN 2021
  • FIGURE 32: NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 33: EUROPE: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 34: ASIA: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 35: ROW: VASCULAR STENTS MARKET SNAPSHOT
  • FIGURE 36: MNM DIVE-VENDOR COMPARISON MATRIX
  • FIGURE 37: GEOGRAPHIC REVENUE MIX OF THE TOP PLAYERS IN THE VASCULAR STENTS MARKET
  • FIGURE 38: MEDTRONIC PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 39: MEDTRONIC PLC: PRODUCT OFFERING SCORECARD
  • FIGURE 40: MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD
  • FIGURE 41: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 42: ABBOTT LABORATORIES: PRODUCT OFFERING SCORECARD
  • FIGURE 43: ABBOTT LABORATORIES: BUSINESS STRATEGY SCORECARD
  • FIGURE 44: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 45: BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 46: BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 47: BIOTRONIK SE & CO. KG: PRODUCT OFFERING SCORECARD
  • FIGURE 48: BIOTRONIK SE & CO. KG: BUSINESS STRATEGY SCORECARD
  • FIGURE 49: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016)
  • FIGURE 50: B. BRAUN MELSUNGEN AG: PRODUCT OFFERING SCORECARD
  • FIGURE 51: B. BRAUN MELSUNGEN AG: BUSINESS STRATEGY SCORECARD
  • FIGURE 52: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 53: TERUMO CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 54: TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 55: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 56: MICROPORT SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 57: MICROPORT SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 58: MERIL LIFE SCIENCES PVT. LTD: PRODUCT OFFERING SCORECARD
  • FIGURE 59: MERIL LIFE SCIENCES PVT. LTD: BUSINESS STRATEGY SCORECARD
  • FIGURE 60: VASCULAR CONCEPTS LIMITED: PRODUCT OFFERING SCORECARD
  • FIGURE 61: VASCULAR CONCEPTS LIMITED: BUSINESS STRATEGY SCORECARD
  • FIGURE 62: C.R. BARD, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 63: C.R. BARD: PRODUCT OFFERING SCORECARD
  • FIGURE 64: C.R. BARD: BUSINESS STRATEGY SCORECARD
  • FIGURE 65: W. L. GORE & ASSOCIATES, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 66: W. L. GORE & ASSOCIATES, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 67: ENDOLOGIX, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 68: ENDOLOGIX, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 69: ENDOLOGIX, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 70: LOMBARD MEDICAL: COMPANY SNAPSHOT (2015)
  • FIGURE 71: LOMBARD MEDICAL: PRODUCT OFFERING SCORECARD
  • FIGURE 72: LOMBARD MEDICAL: BUSINESS STRATEGY SCORECARD
  • FIGURE 73: TRANSLUMINA GMBH: PRODUCT OFFERING SCORECARD
  • FIGURE 74: TRANSLUMINA: BUSINESS STRATEGY SCORECARD
  • FIGURE 75: JOTEC GMBH: PRODUCT OFFERING SCORECARD
  • FIGURE 76: JOTEC GMBH: BUSINESS STRATEGY SCORECARD
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.